Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01746472 · ClinicalTrials.gov registry record · NA
Study of the Diffusion of a Smoking Cessation Application Through an Online Network
A NA study, sponsored by Truth Initiative.
- Completed
- Registry status
- NA
- Development phase
- 11,413
- Enrollment target
NCT01746472: Completed NA study, sponsored by Truth Initiative.
NCT01746472 is a NA study that has completed, run by Truth Initiative. The registered enrollment target is 11,413 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (713% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01746472, a NA study, has completed, sponsored by Truth Initiative.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,413 participants
- Enrollment target
Study Summary
Effective evidence-based interventions exist for smoking cessation delivered over the Internet, but consumer acceptance and adherence remains low. Scalable and efficient mechanisms to disseminate these interventions online are needed, and existing online social networks provide a potential mechanism. This is a proposal for a randomized, factorial trial of the dissemination of an evidence-based intervention through the massive Facebook social network, with the goal of determining intervention characteristics that drive viral spread.
Primary Outcome
The investigators will measure the reproductive rate for each condition, in other words the average number of additional individuals that install the application for each original individual recruited to participate. Higher reproductive rates indicate more efficient and faster dissemination.
Interventions
- BEHAVIORAL Facebook app - condition t
- BEHAVIORAL Facebook app - condition z
- BEHAVIORAL Facebook app - condition B-active
- BEHAVIORAL Facebook app - condition B-passive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,413 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT01746472 record still lists
NCT01746472 is an interventional study that assigns participants to a tested intervention. Its 11,413 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (713% higher).
The record links to 0 conditions, and to 4 interventions - of which Facebook app - condition t is the first listed.
NCT01746472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01746472 about?
NCT01746472 is a clinical study titled "Study of the Diffusion of a Smoking Cessation Application Through an Online Network". Effective evidence-based interventions exist for smoking cessation delivered over the Internet, but consumer acceptance and adherence remains low. Scalable and efficient mechanisms to disseminate these interventions online are needed, and existing online social networks provide a potential mechanism...
What is the current status of trial NCT01746472?
This trial is currently completed. It is a NA study. The enrollment target is 11,413 participants. The study started on 2012-12. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01746472?
The interventions under investigation include: Facebook app - condition t (BEHAVIORAL), Facebook app - condition z (BEHAVIORAL), Facebook app - condition B-active (BEHAVIORAL), Facebook app - condition B-passive (BEHAVIORAL).
Who is sponsoring clinical trial NCT01746472?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01746472's enrollment target sits among peer trials
11,413 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia